Millions need eyeglasses but don’t have them
CHICAGO (Reuters) - More than 1 billion people globally suffer from a condition in which the eye’s lens loses flexibility, blurring objects close by, and half of them do not own eyeglasses to help them see, researchers said on Monday.
In 2005, an estimated 517 million people with presbyopia — which is thought to be caused by a stiffening of the eyes’ lenses or a weakening of muscles that focus the lens — lacked eyeglasses or had an inadequate pair.
Of the 410 million people whose presbyopia left them unable to perform tasks requiring near vision, 94 percent lived in the developing world, according to researchers from the University of New South Wales, Sydney, Australia.
Extrapolating from U.S. Census data on world populations, researcher Brien Holden and colleagues estimated the number of presbyopia cases globally will grow to 1.8 billion by 2050, adding to the demand for eyeglasses.
The condition commonly afflicts the elderly.
“Without intervention to make spectacles more accessible, the global number of individuals who will have a disability associated with uncorrected presbyopia is predicted to grow to 563 million people by 2020,” Holden wrote in the Archives of Ophthalmology.
A second study in the journal predicted a jump in the number of U.S. cases of diabetes-related vision loss.
Cases of diabetic retinopathy, in which the disease damages small blood vessels in the retina, will climb to 16 million Americans by 2050 from 5.5 million in 2004, according to researchers at the U.S. Centers for Disease Control and Prevention, Atlanta.
Diabetics are also more likely to develop cataracts and glaucoma, the report said.
“Vision loss related to eye disease among people with diabetes is an important disability that threatens independence and can lead to depression, reduced mobility and reduced quality of life,” wrote researcher Jinan Saaddine and colleagues.
(Reporting by Andrew Stern; editing by Michael Conlon)
--------------------------------------------------------------------------------------------Related Posts:
By Michael Kahn LONDON (Reuters) - A drug developed to fight leukemia appears to stop multiple sclerosis in its early stages and restore lost function to patients, British researchers said on Wednesday. The three-year study of Bayer AG and Genzyme Corp’s alemtuzumab for the first time show long-term improvement in disability, Alasdair Cole, a neurologist at the
Full Post: Leukemia drug appears to stop early stage MS
--------------------------------------------------------------------------------------------
WASHINGTON (Reuters) - More than 54 million U.S. residents, or about 19 percent of the population, have some sort of disability, the U.S. Census Bureau reported on Thursday. The numbers, based on 2005 data, are up slightly from the 2002 survey when 51.2 million people or 18 percent reported a disability, the census found. About 46 percent
Full Post: More than 54 million disabled in U.S., census says
--------------------------------------------------------------------------------------------
By Jeremy Pelofsky WASHINGTON (Reuters) - The United States has reached the goal of treating 2 million people infected with the virus that causes AIDS months early, President George W. Bush said on Monday, highlighting a bright spot of his tenure before he leaves office next month. Bush and Congress initiated the President’s Emergency Plan for AIDS
Full Post: Bush says U.S. meets HIV treatment goal early
--------------------------------------------------------------------------------------------
By Anne Harding NEW YORK (Reuters Health) - Instituting a law requiring drivers who are 80 years old or older to have their eyes checked reduced fatalities among these motorists, new research from Florida shows. “Vision rescreening laws appear to be effective, but why they’re effective remains an unanswered question,” Dr. Gerald McGwin, Jr. of the University
Full Post: Vision tests cut death rates for older drivers
--------------------------------------------------------------------------------------------
By Michael Kahn LONDON (Reuters) - Near-universal HIV tests and immediate drug treatment for people who test positive would almost eliminate transmission of the deadly virus within a decade, a computer model showed on Wednesday. Doing this would cost more initially but then save money down the road because there would be fewer HIV-infected people to treat,
Full Post: Universal HIV tests would have big impact: study